On January 13, Associate Professor of Medicine Chris Holmes, M.D., Ph.D., and Professor of Medicine Richard Galbraith, M.D., Ph.D., assumed duties as interim co-directors of the University of Vermont Cancer Center. They replace Perelman Professor in Cancer Research and Chair of Biochemistry Gary Stein, Ph.D., who stepped down from his role as director earlier this month. 

Dr. Holmes, who also serves as interim chief of the Division of Hematology and Oncology, has been serving the Cancer Center for decades in numerous leadership roles in translational science, clinical research, and medical oncology. Dr. Galbraith has a long successful history of academic medicine leadership and is in the process of stepping down as UVM's vice president for research. 

Drs. Holmes and Galbraith will serve as interim co-directors while the College undertakes a national search for a permanent director.